Axogen (AXGN) Return on Capital Employed (2011 - 2026)
Axogen (AXGN) recorded quarterly Return on Capital Employed of 3.93% in Q1 2026, up 2.14% quarter-over-quarter from 4.02% in Q4 2025, and down 371.0% on a YoY basis from 1.45% in Q1 2025.
Axogen (AXGN) Return on Capital Employed (2011 - 2026) Analysis & Trends
Axogen's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 3.93% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 371.0% year-over-year to 3.93%; the TTM figure through Mar 2026 stood at 3.93% (down 371.0% YoY), while the FY2025 annual figure was 4.15%, down 221.0% from the prior year.
- Return on Capital Employed was 3.93% for Q1 2026 at Axogen, up from 4.02% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 2.15% in Q3 2025 to a low of 18.04% in Q2 2022.
- Historically, Return on Capital Employed has averaged 9.24% across 5 years, with a median of 11.07% in 2024.
- The sharpest annual moves came in 2022 and 2024: Return on Capital Employed plunged 718 bps in 2022, then surged 1102 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 17.3% in 2022, then rose by 25 bps to 12.98% in 2023, then soared by 85 bps to 1.97% in 2024, then tumbled by 104 bps to 4.02% in 2025, then rose by 2 bps to 3.93% in 2026.
- The last three Return on Capital Employed figures came in at 3.93% (Q1 2026), 4.02% (Q4 2025), and 2.15% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Axogen | 2.32 Bn | 2.22 Bn | 46.19 Mn | -3.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.93% |
| Dec 31, 2025 | -4.02% |
| Sep 30, 2025 | 2.15% |
| Jun 30, 2025 | 0.97% |
| Mar 31, 2025 | -0.22% |
| Dec 31, 2024 | -1.97% |
| Sep 30, 2024 | -5.08% |
| Jun 30, 2024 | -7.43% |
| Mar 31, 2024 | -11.07% |
| Dec 31, 2023 | -12.98% |
| Sep 30, 2023 | -14.34% |
| Jun 30, 2023 | -14.83% |
| Mar 31, 2023 | -15.03% |
| Dec 31, 2022 | -17.30% |
| Sep 30, 2022 | -17.10% |
| Jun 30, 2022 | -18.04% |
| Mar 31, 2022 | -16.95% |
| Dec 31, 2021 | -13.76% |
| Sep 30, 2021 | -13.61% |
| Jun 30, 2021 | -10.86% |